Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Zalicus Inc.

InCarda Gets $30m Closer To Inhalable AF Drug/Device Therapy

The first close of a series C financing should enable InRhythm to enter Phase III as an inhalable anti-arrhythmic for paroxysmal atrial fibrillation in a medically supervised setting.

Financing Research and Development Strategies

Allergy Therapeutics Takes First Steps Into Broader Vaccine Field

Allergy Therapeutics is keen to extend its early R&D pipeline into non-allergy areas through extending its tie-up with Saiba and DeepVax on their virus-like particle technology.

Deals Immune Disorders

Nyxoah Plans $70M+ IPO As It Starts IDE Trial For Neurostim Apnea Device

Belgian firm will float on Euronext Brussels; ResMed and Cochlear among existing investors who will invest in at least 25% of shares.

Financing Companies

Anergis And Virometix Collaborate On Fast-Acting Allergy Immunotherapy

An ultra-fast-acting allergy immunotherapy to induce tolerance to house dust mites is being sought in a collaboration between two Swiss biotechs, Anergis and Virometix.

Deals Immune Disorders
See All

Company Information

  • Other Names / Subsidiaries
    • CombinatoRx, Inc.
    • Neuromed Pharmaceuticals Inc.
UsernamePublicRestriction

Register